Yinjie Su

801 total citations
14 papers, 521 citations indexed

About

Yinjie Su is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Yinjie Su has authored 14 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Yinjie Su's work include Circular RNAs in diseases (8 papers), MicroRNA in disease regulation (8 papers) and Cancer-related molecular mechanisms research (4 papers). Yinjie Su is often cited by papers focused on Circular RNAs in diseases (8 papers), MicroRNA in disease regulation (8 papers) and Cancer-related molecular mechanisms research (4 papers). Yinjie Su collaborates with scholars based in China and Hong Kong. Yinjie Su's co-authors include Tianxin Lin, Luping Chen, Juanyi Shi, Jian Huang, Junming Bi, Wei Dong, Jian Huang, Qianghua Zhou, Hongwei Liu and Meihua Yang and has published in prestigious journals such as International Journal of Molecular Sciences, Molecular Cancer and International Journal of Nanomedicine.

In The Last Decade

Yinjie Su

14 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yinjie Su China 10 458 384 47 47 33 14 521
Dali Yan China 12 390 0.9× 345 0.9× 40 0.9× 44 0.9× 99 3.0× 14 503
Weijie Dai China 13 275 0.6× 183 0.5× 39 0.8× 52 1.1× 42 1.3× 27 359
Siqi Wu China 10 301 0.7× 224 0.6× 35 0.7× 39 0.8× 25 0.8× 14 341
Sandra Santasusagna Spain 12 431 0.9× 392 1.0× 26 0.6× 52 1.1× 64 1.9× 13 511
Qiou Gu China 9 521 1.1× 380 1.0× 21 0.4× 60 1.3× 94 2.8× 10 603
Yugang Ge China 11 256 0.6× 207 0.5× 34 0.7× 44 0.9× 53 1.6× 17 330
Zehui Hou China 11 265 0.6× 223 0.6× 22 0.5× 34 0.7× 55 1.7× 20 341

Countries citing papers authored by Yinjie Su

Since Specialization
Citations

This map shows the geographic impact of Yinjie Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinjie Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinjie Su more than expected).

Fields of papers citing papers by Yinjie Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinjie Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinjie Su. The network helps show where Yinjie Su may publish in the future.

Co-authorship network of co-authors of Yinjie Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yinjie Su. A scholar is included among the top collaborators of Yinjie Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinjie Su. Yinjie Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Qiao, Yi, et al.. (2025). Nanoparticle-Based Strategies to Enhance the Efficacy of STING Activators in Cancer Immunotherapy. International Journal of Nanomedicine. Volume 20. 5429–5456. 3 indexed citations
2.
Gao, He, et al.. (2024). Realization of inverse-designed underwater acoustic superscattering. Physical Review Applied. 21(6). 2 indexed citations
3.
Su, Yinjie, Bo Wang, Jian Huang, Ming Huang, & Tianxin Lin. (2023). YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer. Cell Proliferation. 56(7). e13404–e13404. 32 indexed citations
4.
Zhang, Zhilei, Yonghua Wang, Xiangyan Zhang, et al.. (2023). Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression. iScience. 26(11). 108142–108142. 7 indexed citations
5.
Su, Yinjie, et al.. (2021). Correction to: circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway. Molecular Cancer. 20(1). 1–1. 23 indexed citations
6.
Su, Yinjie, et al.. (2020). circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway. Molecular Cancer. 19(1). 23–23. 120 indexed citations
7.
Shi, Juanyi, Cheng Liu, Changhao Chen, et al.. (2020). Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis. Aging. 12(13). 13255–13280. 44 indexed citations
8.
Dong, Wei, Junming Bi, Hongwei Liu, et al.. (2019). Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axis. Molecular Cancer. 18(1). 95–95. 135 indexed citations
9.
Su, Yinjie, Weiping Yang, Ning Jiang, et al.. (2019). Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance. International Journal of Biological Sciences. 15(2). 441–452. 72 indexed citations
10.
Su, Yinjie, et al.. (2019). ciRs-6 upregulates March1 to suppress bladder cancer growth by sponging miR-653. Aging. 11(23). 11202–11223. 19 indexed citations
11.
Su, Yinjie, Junming Bi, Juanyi Shi, et al.. (2019). circ5912 suppresses cancer progression via inducing MET in bladder cancer. Aging. 11(23). 10826–10838. 10 indexed citations
12.
Su, Yinjie, Guangzheng Zhong, Ning Jiang, Ming Huang, & Tianxin Lin. (2018). Circular RNA, a novel marker for cancer determination (Review). International Journal of Molecular Medicine. 42(4). 1786–1798. 15 indexed citations
13.
Su, Yinjie, Jin Yu, Yaqin Huang, & Jin Yang. (2015). Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer. International Journal of Molecular Sciences. 16(6). 13322–13338. 36 indexed citations
14.
Su, Yinjie, et al.. (2015). Bariatric surgery: beta cells in type 2 diabetes remission. Diabetes/Metabolism Research and Reviews. 32(2). 122–131. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dali Yan Breakdown of academic impact, for papers by Weijie Dai Breakdown of academic impact, for papers by Siqi Wu Breakdown of academic impact, for papers by Sandra Santasusagna Breakdown of academic impact, for papers by Qiou Gu Breakdown of academic impact, for papers by Yugang Ge Breakdown of academic impact, for papers by Zehui Hou
Rankless by CCL
2026